| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 89.23B | 89.66B | 108.71B | 94.68B | 98.94B | 56.75B |
| Gross Profit | 25.98B | 26.45B | 22.29B | 22.73B | 23.30B | 16.03B |
| EBITDA | 10.44B | 10.61B | 11.71B | 10.23B | 11.33B | 7.12B |
| Net Income | 5.92B | 5.92B | 6.50B | 5.38B | 6.71B | 2.90B |
Balance Sheet | ||||||
| Total Assets | 87.15B | 76.52B | 88.82B | 87.34B | 87.74B | 65.24B |
| Cash, Cash Equivalents and Short-Term Investments | 10.35B | 7.58B | 7.70B | 11.73B | 14.94B | 7.22B |
| Total Debt | 35.74B | 20.79B | 29.89B | 22.11B | 25.98B | 24.51B |
| Total Liabilities | 61.82B | 49.13B | 62.07B | 53.98B | 53.18B | 38.19B |
| Stockholders Equity | 24.39B | 26.43B | 25.71B | 32.40B | 33.62B | 26.34B |
Cash Flow | ||||||
| Free Cash Flow | 5.31B | 9.68B | 12.87B | 7.72B | 12.19B | 6.92B |
| Operating Cash Flow | 5.80B | 10.25B | 13.84B | 9.70B | 13.72B | 7.90B |
| Investing Cash Flow | -514.70M | -401.90M | -716.60M | -1.95B | -1.51B | -1.11B |
| Financing Cash Flow | 1.26B | -9.88B | -16.83B | -10.17B | -3.52B | -7.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$2.29B | 3.61 | 5.10% | 4.05% | 6.60% | -14.32% | |
73 Outperform | HK$13.82B | 5.90 | 9.54% | 4.43% | 10.89% | 2.02% | |
64 Neutral | HK$110.59B | 15.23 | 23.74% | 4.21% | -9.49% | 32.56% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$9.42B | 4.77 | 12.17% | 4.60% | -10.41% | 67.25% | |
60 Neutral | HK$8.87B | 7.20 | 20.83% | 1.70% | ― | ― | |
44 Neutral | HK$176.92M | -2.42 | -43.66% | ― | -27.28% | 47.40% |